Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone

Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone — Trials · CancerIndex

Clinical trials

Registered studies

22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–22 of 22 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07609277	TRACP-5b for Diagnosis and Follow-up of Giant Cell Tumor of Bone	recruiting	—	70	St. Anne's University Hospital Brno, Czech RepublicOTHER	1	May 27, 2026	clinicaltrials
NCT03449108	LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas	active not recruiting	Phase 2	30	M.D. Anderson Cancer CenterOTHER	1	May 22, 2026